AAAAAA
Results:
1-10
|
Results: 10
Authors:
ALAKOKKO TI
ALAHUHTA S
ARVELA P
VAHAKANGAS K
Citation: Ti. Alakokko et al., MATERNAL, FETAL AND PLACENTAL DISTRIBUTION OF LIDOCAINE-EPINEPHRINE AND BUPIVACAINE AFTER EPIDURAL ADMINISTRATION FOR CESAREAN-SECTION, International journal of obstetric anesthesia, 7(2), 1998, pp. 82-87
Authors:
PIENIMAKI P
LAMPELA E
HAKKOLA J
ARVELA P
RAUNIO H
VAHAKANGAS K
Citation: P. Pienimaki et al., PHARMACOKINETICS OF OXCARBAZEPINE AND CARBAMAZEPINE IN HUMAN PLACENTA, Epilepsia, 38(3), 1997, pp. 309-316
Authors:
CASTREN K
PIENIMAKI P
ARVELA P
VAHAKANGAS K
Citation: K. Castren et al., METABOLITES AND DNA-BINDING OF CARBAMAZEPINE AND OXCARBAZEPINE IN-VITRO BY RAT-LIVER MICROSOMES, Human & experimental toxicology, 15(7), 1996, pp. 577-582
Authors:
SOTANIEMI EA
LUMME P
ARVELA P
RAUTIO A
Citation: Ea. Sotaniemi et al., AGE AND CYP3A4 AND CYP2A6 ACTIVITIES MARKED BY THE METABOLISM OF LIGNOCAINE AND COUMARIN IN MAN, Therapie, 51(4), 1996, pp. 363-366
Authors:
KLEBOVICH I
RAUTIO A
SALONPAA P
ARVELA P
PELKONEN O
SOTANIEMI EA
Citation: I. Klebovich et al., ANTIPYRINE, COUMARIN AND GLIPIZIDE AFFECT N-ACETYLATION MEASURED BY CAFFEINE TEST, Biomedicine & pharmacotherapy, 49(5), 1995, pp. 225-227
Authors:
SOTANIEMI EA
RAUTIO A
BACKSTROM M
ARVELA P
PELKONEN O
Citation: Ea. Sotaniemi et al., CYP3A4 AND CYP2A6 ACTIVITIES MARKED BY THE METABOLISM OF LIGNOCAINE AND COUMARIN IN PATIENTS WITH LIVER AND KIDNEY-DISEASES AND EPILEPTIC PATIENTS, British journal of clinical pharmacology, 39(1), 1995, pp. 71-76
Authors:
PIENIMAKI P
HARTIKAINEN AL
ARVELA P
PARTANEN T
HERVA R
PELKONEN O
VAHAKANGAS K
Citation: P. Pienimaki et al., CARBAMAZEPINE AND ITS METABOLITES IN HUMAN PERFUSED PLACENTA AND IN MATERNAL AND CORD-BLOOD, Epilepsia, 36(3), 1995, pp. 241-248
Authors:
ARVELA P
FROLOV AV
JAAKKOLA S
KATUNIN AY
LUKASHEVICH II
MERTIG M
SAFONOV AI
TSUKANOV E
Citation: P. Arvela et al., STRONG MAGNETIC COMPRESSION OF SPIN-POLARIZED HYDROGEN, Physica. B, Condensed matter, 194, 1994, pp. 441-442
Authors:
MUSTAJOKI P
MUSTAJOKI S
RAUTIO A
ARVELA P
PELKONEN O
Citation: P. Mustajoki et al., EFFECTS OF HEME ARGINATE ON CYTOCHROME-P450 - MEDIATED METABOLISM OF DRUGS IN PATIENTS WITH VARIEGATE PORPHYRIA AND IN HEALTHY-MEN, Clinical pharmacology and therapeutics, 56(1), 1994, pp. 9-13
Authors:
KLEBOVICH I
ARVELA P
PELKONEN O
Citation: I. Klebovich et al., HPLC METHOD FOR RAPID-DETERMINATION OF ACETYLATOR PHENOTYPE BY MEASURING URINARY CAFFEINE METABOLITES, Journal of pharmaceutical and biomedical analysis, 11(10), 1993, pp. 1017-1021
Risultati:
1-10
|